Your browser doesn't support javascript.
loading
Therapeutic blockade of ER stress and inflammation prevents NASH and progression to HCC.
Boslem, Ebru; Reibe, Saskia; Carlessi, Rodrigo; Smeuninx, Benoit; Tegegne, Surafel; Egan, Casey L; McLennan, Emma; Terry, Lauren V; Nobis, Max; Mu, Andre; Nowell, Cameron; Horadagoda, Neil; Henstridge, Darren C; Mellett, Natalie A; Timpson, Paul; Jones, Matthew; Denisenko, Elena; Forrest, Alistair R R; Tirnitz-Parker, Janina E E; Meikle, Peter J; Rose-John, Stefan; Karin, Michael; Febbraio, Mark A.
Afiliação
  • Boslem E; Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia.
  • Reibe S; Garvan Institute of Medical Research, Sydney, Australia.
  • Carlessi R; Harry Perkins Institute of Medical Research, QEII Medical Centre and Centre for Medical Research, The University of Western Australia, Nedlands, WA 6009, Australia.
  • Smeuninx B; Curtin Medical School, Curtin Health Innovation Research Institute, Curtin University, Bentley, WA 6102, Australia.
  • Tegegne S; Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia.
  • Egan CL; Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia.
  • McLennan E; Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia.
  • Terry LV; Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia.
  • Nobis M; Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia.
  • Mu A; Garvan Institute of Medical Research, Sydney, Australia.
  • Nowell C; Wellcome Sanger Institute, Cambridge, UK.
  • Horadagoda N; EMBL's European Bioinformatics Institute, Cambridge UK.
  • Henstridge DC; Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia.
  • Mellett NA; Faculty of Veterinary Science, University of Sydney, Camden, Australia.
  • Timpson P; Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
  • Jones M; Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
  • Denisenko E; Garvan Institute of Medical Research, Sydney, Australia.
  • Forrest ARR; Harry Perkins Institute of Medical Research, QEII Medical Centre and Centre for Medical Research, The University of Western Australia, Nedlands, WA 6009, Australia.
  • Tirnitz-Parker JEE; Harry Perkins Institute of Medical Research, QEII Medical Centre and Centre for Medical Research, The University of Western Australia, Nedlands, WA 6009, Australia.
  • Meikle PJ; Harry Perkins Institute of Medical Research, QEII Medical Centre and Centre for Medical Research, The University of Western Australia, Nedlands, WA 6009, Australia.
  • Rose-John S; Curtin Medical School, Curtin Health Innovation Research Institute, Curtin University, Bentley, WA 6102, Australia.
  • Karin M; Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
  • Febbraio MA; Department of Biochemistry, Christian-Albrechts-Universität zu Kiel, Kiel, Germany.
Sci Adv ; 9(37): eadh0831, 2023 09 15.
Article em En | MEDLINE | ID: mdl-37703359
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article